@article{tsakris.etal_2023,
  title = {Preface},
  author = {Tsakris, Athanasios and Hurley, James and Johnson, Alan and Lewis, Russell},
  year = {2023},
  month = may,
  journal = {Journal of Antimicrobial Chemotherapy},
  volume = {78},
  number = {Supplement\_1},
  pages = {i1},
  issn = {0305-7453},
  doi = {10.1093/jac/dkad084},
  urldate = {2024-05-17},
  abstract = {Streptococcus pneumoniae continues to be a major cause of morbidity and mortality worldwide, associated with invasive (e.g. bacteraemia, meningitis) and non-invasive (e.g. community-acquired respiratory tract) infections. Invasive pneumococcal disease (IPD) is an ongoing threat to global health, with severe socio-economic impacts, and MDR S. pneumoniae is a potentially emerging concern amongst IPD.This Supplement to the Journal of Antimicrobial Chemotherapy (JAC) comprises five articles that provide a comprehensive examination of the changing patterns of antimicrobial resistance, serotype distribution, genotypic relatedness and virulence of invasive S. pneumoniae isolates obtained across Canada over a 10 year period of the SAVE study. SAVE is an ongoing, annual, national study between the Canadian Antimicrobial Resistance Alliance (CARA) and the National Microbiology Laboratory, focused on characterizing invasive isolates of S. pneumoniae obtained across Canada. Some very interesting findings of this national survey, covering the period between 2011 and 2015, have been published in a previous supplement of JAC (Vol. 73, Suppl 7, July 2018).},
  file = {/Users/russelllewis/Zotero/storage/4VFCV93S/7147759.html}
}

{"_id":"ypT7DzPxAXDehpMni","bibbaseid":"tsakris-hurley-johnson-lewis-preface-2023","author_short":["Tsakris, A.","Hurley, J.","Johnson, A.","Lewis, R."],"bibdata":{"bibtype":"article","type":"article","title":"Preface","author":[{"propositions":[],"lastnames":["Tsakris"],"firstnames":["Athanasios"],"suffixes":[]},{"propositions":[],"lastnames":["Hurley"],"firstnames":["James"],"suffixes":[]},{"propositions":[],"lastnames":["Johnson"],"firstnames":["Alan"],"suffixes":[]},{"propositions":[],"lastnames":["Lewis"],"firstnames":["Russell"],"suffixes":[]}],"year":"2023","month":"May","journal":"Journal of Antimicrobial Chemotherapy","volume":"78","number":"Supplement_1","pages":"i1","issn":"0305-7453","doi":"10.1093/jac/dkad084","urldate":"2024-05-17","abstract":"Streptococcus pneumoniae continues to be a major cause of morbidity and mortality worldwide, associated with invasive (e.g. bacteraemia, meningitis) and non-invasive (e.g. community-acquired respiratory tract) infections. Invasive pneumococcal disease (IPD) is an ongoing threat to global health, with severe socio-economic impacts, and MDR S. pneumoniae is a potentially emerging concern amongst IPD.This Supplement to the Journal of Antimicrobial Chemotherapy (JAC) comprises five articles that provide a comprehensive examination of the changing patterns of antimicrobial resistance, serotype distribution, genotypic relatedness and virulence of invasive S. pneumoniae isolates obtained across Canada over a 10 year period of the SAVE study. SAVE is an ongoing, annual, national study between the Canadian Antimicrobial Resistance Alliance (CARA) and the National Microbiology Laboratory, focused on characterizing invasive isolates of S. pneumoniae obtained across Canada. Some very interesting findings of this national survey, covering the period between 2011 and 2015, have been published in a previous supplement of JAC (Vol. 73, Suppl 7, July 2018).","file":"/Users/russelllewis/Zotero/storage/4VFCV93S/7147759.html","bibtex":"@article{tsakris.etal_2023,\n title = {Preface},\n author = {Tsakris, Athanasios and Hurley, James and Johnson, Alan and Lewis, Russell},\n year = {2023},\n month = may,\n journal = {Journal of Antimicrobial Chemotherapy},\n volume = {78},\n number = {Supplement\\_1},\n pages = {i1},\n issn = {0305-7453},\n doi = {10.1093/jac/dkad084},\n urldate = {2024-05-17},\n abstract = {Streptococcus pneumoniae continues to be a major cause of morbidity and mortality worldwide, associated with invasive (e.g. bacteraemia, meningitis) and non-invasive (e.g. community-acquired respiratory tract) infections. Invasive pneumococcal disease (IPD) is an ongoing threat to global health, with severe socio-economic impacts, and MDR S. pneumoniae is a potentially emerging concern amongst IPD.This Supplement to the Journal of Antimicrobial Chemotherapy (JAC) comprises five articles that provide a comprehensive examination of the changing patterns of antimicrobial resistance, serotype distribution, genotypic relatedness and virulence of invasive S. pneumoniae isolates obtained across Canada over a 10 year period of the SAVE study. SAVE is an ongoing, annual, national study between the Canadian Antimicrobial Resistance Alliance (CARA) and the National Microbiology Laboratory, focused on characterizing invasive isolates of S. pneumoniae obtained across Canada. Some very interesting findings of this national survey, covering the period between 2011 and 2015, have been published in a previous supplement of JAC (Vol. 73, Suppl 7, July 2018).},\n file = {/Users/russelllewis/Zotero/storage/4VFCV93S/7147759.html}\n}\n\n","author_short":["Tsakris, A.","Hurley, J.","Johnson, A.","Lewis, R."],"key":"tsakris.etal_2023","id":"tsakris.etal_2023","bibbaseid":"tsakris-hurley-johnson-lewis-preface-2023","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/a6GBPjh3wXfA46RXX/CV.bib","dataSources":["qLqjc4bwMYLmk2F3c","8E62bsJiEchQrmW6z"],"keywords":[],"search_terms":["preface","tsakris","hurley","johnson","lewis"],"title":"Preface","year":2023}